Matt Brams
Cingulate Therapeutics · Cingulate · Sponsor Medical Officer
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Matt Brams as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:10 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07119073 · In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)Cingulate Therapeutics · completed · Healthy Volunteers in Fed and Fasted State · study director
- Ph3NCT05924594 · Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301Cingulate Therapeutics · suspended · ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity · study director
- Ph3NCT05286762 · Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301Cingulate Therapeutics · completed · ADHD, Attention Deficit Hyperactivity Disorder, ADHD - Combined Type · study director
- Ph1NCT04449250 · Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy SubjectsCingulate Therapeutics · completed · Healthy Volunteers in Fed and Fasted State · study director
- Ph1/Ph2NCT04138498 · CTx-1301 Comparative Bioavailability StudyCingulate Therapeutics · completed · ADHD · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:10 UTC. The ranking covers the 200 most relevant of 31 PubMed records, and a shared surname and initials can bring in a namesake. All 31 on PubMed
- 115 citationsRCR 4.6
- Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.Pediatrics · 201189 citationsRCR 3.6
- A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry · 201282 citationsRCR 3.4
- Lurasidone for the Treatment of Irritability Associated with Autistic Disorder.J Autism Dev Disord · 201656 citationsRCR 2.7
- Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.J Child Adolesc Psychopharmacol · 201148 citationsRCR 2.1
- Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.J Child Adolesc Psychopharmacol · 200640 citationsRCR 1.4
- Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.J Child Adolesc Psychopharmacol · 200539 citationsRCR 1.5
- Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study.J Child Adolesc Psychopharmacol · 200838 citationsRCR 1.4
- Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.J Clin Psychiatry · 201238 citationsRCR 1.6
- 36 citationsRCR 1.5